Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.86 USD | +9.78% | +25.16% | -43.62% |
Jul. 09 | RBC Cuts Price Target on Verve Therapeutics to $25 From $35, Keeps Outperform, Speculative Risk | MT |
Jun. 28 | Verve Therapeutics, Inc. Announces Board and Committee Appointments | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VERVE THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +9.78% | +25.16% | -43.62% | -60.58% | - | 660M |
Technical Rankings Surperformance
- Stock Market
- Equities
- VERV Stock
- Charts Verve Therapeutics, Inc.
- Comparison Chart